Pay in 4 interest-free payments of $5.95 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Food and Drug Administration (FDA) released the following Class I recall information in its January 9, 2002 Enforcement Report
A., Harish, Varjani, S., Singh, G., Marchand, J., Schoefs, B., & Vinayak, V
- Daily Dosage: Unlike B12 shots, which may only be needed monthly, oral supplements typically require daily intake
Important Safety Information Do not use AOD-9604 if you: Have a known hypersensitivity to growth hormone fragments or any component of the formulation Have active malignancy (cancer that is currently being treated or monitored) Are pregnant or breastfeeding (insufficient safety data) Have a history of severe allergic reactions to peptide therapies Common side effects (typically mild and transient): Headache, mild gastrointestinal disturbances (flatulence, mild diarrhea at higher doses), upper respiratory tract symptoms, injection site reactions (redness, mild discomfort) Seek medical attention if you experience: Signs of allergic reaction (hives, difficulty breathing, swelling of face or throat), persistent gastrointestinal symptoms, unexplained significant changes in energy, mood, or physical symptoms Clinical Safety Data Safety studies involving approximately 900 participants across six randomized controlled trials documented that AOD-9604 displayed a very good safety and tolerability profile indistinguishable from placebo across most parameters
B.SpanoM.SobolevA
Results Development of JMF4073 as an inhibitor of TMPK and CMPK The survival and growth of cancer cells require a sufficient supply of the four dNTPs for DNA repair and replication
US$ 20.03
US$ 22.45
US$ 27.63
US$ 22.52
